Cited by 35Thyroid Disorders and TreatmentsThyroid and Parathyroid SurgeryThyroid Cancer Diagnosis and Treatment

Evaluation of thyroid hormone replacement dosing in overweight and Obese patients after a thyroidectomy

Papoian, Vardan, Ylli, Dorina, Felger, Erin A., Wartofsky, Leonard, Rosen, Jennifer E.·2019·Thyroid

Abstract

Background: Initiation of thyroid hormone replacement (THR) after a total thyroidectomy has traditionally relied on the weight of the patient, regardless of the patient's body mass index (BMI). Current literature suggests that THR in obese patients differs from nonobese patients. This can lead to overdosing of levothyroxine (LT4) and delay in achievement of euthyroid state. Methods: We retrospectively identified patients on THR after total thyroidectomy with a benign postoperative diagnosis. Patients who achieved euthyroidism with THR were included in the analysis. Patient demographic and THR dosing information was collected. Regression analysis was performed to identify appropriate THR dosing at varying BMIs. This study aimed to evaluate the appropriate dosing of THR in overweight and obese patients. Results: Our cohort consisted of 114 patients achieving euthyroidism while on THR. Mean age was 55 years (range 28–77 years) with 84% females. Of the 114 patients, the number of patients with a BMI less than 25, 25–29, 30–34, 35–39, and greater than 40 were 26 (23%), 33 (29%), 23 (20%), 19 (17%), and 13 (11%), respectively. Of the entire cohort, a mean of 50 weeks elapsed after surgery to achieve euthyroidism, with no significant difference between the BMI categories ( p = 0.58). In obese patients (BMI >30), 35% were overdosed with LT4 on initial dosing. The cohort lost a mean of 3 kg until euthyroidism was achieved, with no significant difference in the weight loss based on BMI category ( p = 0.61). Patients with a higher BMI did require a higher dose (mcg) of LT4 to achieve euthyroidism ( p < 0.01), but the dose was significantly lower in relation to their weight (mcg/kg) ( p < 0.01). The LT4 dose required to achieve euthyroidism based on the previously mentioned BMI categories were 1.76, 1.47, 1.42, 1.27, and 1.28 mcg/kg. Conclusion: The current weight-based dosing of THR inappropriately overdoses overweight and obese patients. A more appropriate formula for THR titration should consider both the weight and BMI of the patient.

Integrity signals

Registry

Crossref · 10.1089/thy.2019.0251

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Papoian, V., Ylli, D., Felger, E. A., Wartofsky, L., & Rosen, J. E.
Affiliations
MedStar Washington Hospital Center (US)
Corresponding author
Papoian, Vardan
Venue
Thyroid
Published
2019-11
Volume
29
Issue
11
Pages
1558-1562
ISSN
  • 1050-7256 (ISSN-L)
  • 1557-9077
OpenAlex
W2972147349
Cited by
35
References
26
Citations by year
2026: 2 · 2025: 8 · 2024: 6 · 2023: 3 · 2022: 8 · 2021: 6 · 2020: 1 · 2019: 1
FWCI
3.25
Type
journal article
Language
en
Open access
closed
Locations
  • Thyroid (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
thyroid hormone replacement, levothyroxine, total thyroidectomy, obesity, overweight, body mass index, levothyroxine dosing, weight-based dosing, dose titration, euthyroidism, weight loss, thyroid autoimmunity, thyroid nodules
MeSH terms
Adult, Age Factors, Aged, Female, Humans, Hypothyroidism, Male, Middle Aged, Obesity, Thyroidectomy, Thyroxine, Cohort Studies, Weight Loss, Body Mass Index, Hormone Replacement Therapy, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review